Information  X 
Enter a valid email address

Company Name matching 'Merus N.V.'

Date
Time Source
Company
Announcement
05 Jun 2022 4:00 pm GNW   Merus N.V. Merus Presents Clinical Data on Zenocutuzumab (Zeno) in NRG1-fusion (NRG1+) Cancer at the 2022 American Society of Clinical Oncology (ASCO) Annual Meeting (Oral Abstract)
03 Jun 2022 1:00 pm GNW   Merus N.V. Merus to Participate in a Fireside Chat at the Jefferies Healthcare Conference
26 May 2022 10:00 pm GNW   Merus N.V. Merus Announces Publication of Abstract of Zenocutuzumab in NRG1-fusion (NRG1+) Cancer at the 2022 American Society of Clinical Oncology (ASCO) Annual Meeting
17 May 2022 1:00 pm GNW   Merus N.V. Merus to Present at the H.C. Wainwright Global Investment Conference
09 May 2022 9:29 pm GNW   Merus N.V. Merus Announces Financial Results for the First Quarter 2022 and Provides Business Update
27 Apr 2022 9:01 pm GNW   Merus N.V. Zenocutuzumab Clinical Abstract Selected for Oral Presentation at the 2022 American Society of Clinical Oncology Annual Meeting
25 Apr 2022 1:00 pm GNW   Merus N.V. Merus Announces Publication in Nature Cancer on Petosemtamab’s (MCLA-158) Unique Mechanism of Action
08 Apr 2022 6:00 pm GNW   Merus N.V. Merus Presents Preclinical Data on MCLA-129 at the American Association for Cancer Research Annual Meeting 2022
06 Apr 2022 1:00 pm GNW   Merus N.V. Merus to Participate in a Fireside Chat at the 21st Annual Needham Virtual Healthcare Conference
08 Mar 2022 9:35 pm GNW   Merus N.V. Merus Announces Publication of Abstract on MCLA-129 at the American Association for Cancer Research 2022 Annual Meeting
28 Feb 2022 9:36 pm GNW   Merus N.V. Merus Announces Financial Results for the Fourth Quarter and Full Year 2021 and Provides Business Update
03 Feb 2022 1:00 pm GNW   Merus N.V. Merus to Participate in Upcoming Investor Conferences
25 Jan 2022 9:30 pm GNW   Merus N.V. Merus Appoints Shannon Campbell as Chief Commercial Officer and Regains Worldwide Rights to MCLA-145
10 Dec 2021 1:00 pm GNW   Merus N.V. Merus Presents Updated Analysis of Zenocutuzumab, Trastuzumab, and Vinorelbine in Patients with HER2+ Metastatic Breast Cancer at the San Antonio Breast Cancer Symposium
06 Dec 2021 11:42 am GNW   Merus N.V. Merus Presents Clinical Data on MCLA-145 at the ESMO Immuno-Oncology Congress 2021
02 Dec 2021 1:00 pm GNW   Merus N.V. Merus Announces Poster Presentation on Clinical Data on MCLA-145 at the ESMO Immuno-Oncology Congress 2021
10 Nov 2021 1:00 pm GNW   Merus N.V. Merus to Participate in a Fireside Chat at the Jefferies London Healthcare Conference (Virtual)
05 Nov 2021 1:01 am GNW   Merus N.V. Merus Announces Pricing of Public Offering of Common Shares
04 Nov 2021 8:07 pm GNW   Merus N.V. Merus N.V. Announces Proposed Public Offering of Common Shares
02 Nov 2021 8:20 pm GNW   Merus N.V. Merus Announces Regulatory Update on Zenocutuzumab, Financial Results for the Third Quarter and Provides Business Update
07 Oct 2021 2:00 pm GNW   Merus N.V. Merus Presents Early Clinical Data on MCLA-158 and Preclinical Data on Zenocutuzumab at the AACR-NCI-EORTC Virtual International Conference on Molecular Targets and Cancer Therapeutics
30 Sep 2021 9:35 pm GNW   Merus N.V. Merus Announces Poster Presentations on Zenocutuzumab and MCLA-158 at the AACR-NCI-EORTC Virtual International Conference on Molecular Targets and Cancer Therapeutics
07 Sep 2021 1:00 pm GNW   Merus N.V. Merus to Participate in Upcoming Investor Conferences
05 Aug 2021 10:00 pm GNW   Merus N.V. Merus Announces Financial Results for the Second Quarter and Provides Business Update
21 Jul 2021 1:00 pm GNW   Merus N.V. Merus Announces Publication in Nature Communications on MCLA-145’s Novel Mechanism of Action Promoting Tumor Immunity and Context Dependent T-Cell Costimulation
07 Jul 2021 9:20 pm GNW   Merus N.V. Merus to Participate in William Blair's Biotech Focus Conference 2021
04 Jun 2021 5:00 pm GNW   Merus N.V. Merus Presents Clinical Data on Zenocutuzumab in NRG1-fusion (NRG1+) Cancers at the American Society of Clinical Oncology (ASCO) 2021 Annual Meeting (Oral Abstract)
26 May 2021 9:01 pm GNW   Merus N.V. Merus to Participate in a Fireside Chat at the Jefferies Virtual Healthcare Conference
19 May 2021 10:01 pm GNW   Merus N.V. Merus Announces Publication of Abstract on Zenocutuzumab in NRG1-fusion (NRG1+) Cancers at the American Society of Clinical Oncology (ASCO) 2021 Annual Meeting
13 May 2021 1:00 pm GNW   Merus N.V. Merus Announces Collaborations in Israel, Italy and Spain to Increase Screening and Identification of Cancer Patients with NRG1 Fusion Tumors and to Raise Awareness of the Phase 1/2 eNRGy Clinical Trial
11 May 2021 1:00 pm GNW   Merus N.V. Merus to Participate in a Fireside Chat at the 2021 RBC Capital Markets Global Healthcare Conference
06 May 2021 10:14 pm GNW   Merus N.V. Merus Announces Financial Results for the First Quarter and Provides Business Update
03 May 2021 9:01 pm GNW   Merus N.V. Merus Announces First Patient Treated in Phase 1/2 Clinical Trial of MCLA-129 in Advanced Lung Cancer and Other Solid Tumors
28 Apr 2021 9:01 pm GNW   Merus N.V. Zenocutuzumab Clinical Data Selected for Oral Presentation at the 2021 American Society of Clinical Oncology Annual Meeting
16 Mar 2021 8:57 pm GNW   Merus N.V. Merus Announces Financial Results for the Fourth Quarter and Full Year 2020 and Provides Business Update
10 Mar 2021 9:45 pm GNW   Merus N.V. Merus Announces Poster Presentations for Zenocutuzumab and MCLA-129 at the American Association for Cancer Research 2021 Annual Meeting
08 Mar 2021 1:00 pm GNW   Merus N.V. Merus to Participate in a Fireside Chat at the 33rd Annual Roth Conference
01 Feb 2021 1:00 pm GNW   Merus N.V. Merus to Participate in Upcoming Investor Conferences
21 Jan 2021 1:40 pm GNW   Merus N.V. Merus Announces Pricing of Public Offering of Common Shares
19 Jan 2021 9:18 pm GNW   Merus N.V. Merus N.V. Announces Proposed Public Offering of Common Shares
12 Jan 2021 9:01 pm GNW   Merus N.V. Merus Announces Collaborations with Nationwide Medical Organizations in the Netherlands and Japan to Enhance Screening and Identification of Cancer Patients with NRG1 Fusion Tumors and to Raise Awareness of the eNRGy Clinical Trial
11 Jan 2021 10:10 pm GNW   Merus N.V. Merus Announces Presentation of Phase 1 Clinical Data for MCLA-158 at the American Society of Clinical Oncology (ASCO) 2021 Gastrointestinal Cancers Symposium
07 Jan 2021 9:05 pm GNW   Merus N.V. Merus Granted FDA Fast Track Designation of Zenocutuzumab for the Treatment of Patients with Neuregulin 1 Fusion Cancers
17 Dec 2020 1:00 pm GNW   Merus N.V. Merus and Sema4 Enter Into an Agreement to Support Merus’ Phase 1/2 Clinical Trial of Zenocutuzumab
16 Nov 2020 1:00 pm GNW   Merus N.V. Merus to Present at the Jefferies Virtual London Healthcare Conference
09 Nov 2020 1:00 pm GNW   Merus N.V. Merus Announces Poster Presentations on MCLA-145 at Society for Immunotherapy of Cancer
05 Nov 2020 9:10 pm GNW   Merus N.V. Merus Announces Financial Results for the Third Quarter and Provides Business Update
12 Oct 2020 10:00 pm GNW   Merus N.V. Merus and myTomorrows Announce Expansion of Collaboration for Screening and eNRGy Clinical Trial Awareness for Cancer Patients with Neuregulin 1 Fusion Tumors
07 Aug 2020 1:30 pm GNW   Merus N.V. Merus to Present at the 2020 Wedbush PacGrow Healthcare Conference
06 Aug 2020 9:07 pm GNW   Merus N.V. Merus Announces Financial Results for the Second Quarter and Provides Business Update
27 Jul 2020 1:00 pm GNW   Merus N.V. Merus Appoints Andrew Joe, M.D., as Chief Medical Officer
  1:00 pm GNW   Merus N.V. Merus announces FDA Orphan Drug Designation of Zenocutuzumab for the Treatment of Pancreatic Cancer
13 Jul 2020 9:01 pm GNW   Merus N.V. Merus and Caris Life Sciences Announce Collaboration to Detect NRG1 Fusions in Cancer Patients
01 Jun 2020 9:05 pm GNW   Merus N.V. Merus to Participate in Fireside Chat at the Jefferies Virtual Healthcare Conference
14 May 2020 2:05 pm GNW   Merus N.V. Merus Announces the Acceptance of Six Abstracts at Upcoming Medical Conferences and Provides Program Updates
11 May 2020 9:36 pm GNW   Merus N.V. Merus Announces Financial Results for the First Quarter and Provides Business Update
12 Mar 2020 8:01 pm GNW   Merus N.V. Merus Announces Financial Results for the Fourth Quarter and Full Year 2019 and Provides Business Update
16 Dec 2019 1:30 pm GNW   Merus N.V. Merus Announces Chief Executive Officer Transition
12 Nov 2019 9:01 pm GNW   Merus N.V. Merus Announces Financial Results for the Third Quarter 2019 and Provides Business Update
05 Nov 2019 1:32 pm GNW   Merus N.V. Merus Announces Pricing of Public Offering of Common Shares


Company Announcements Archive »


a d v e r t i s e m e n t